Skip Navigation


Human Molecular Genetics Advance Access originally published online on July 16, 2008
Human Molecular Genetics 2008 17(20):3118-3127; doi:10.1093/hmg/ddn209
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
17/20/3118    most recent
ddn209v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Benayoun, B. A.
Right arrow Articles by Veitia, R. A.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Benayoun, B. A.
Right arrow Articles by Veitia, R. A.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2008. Published by Oxford University Press. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

The identification and characterization of a FOXL2 response element provides insights into the pathogenesis of mutant alleles

Bérénice A. Benayoun1,2,3,4,5,{dagger}, Sandrine Caburet1,2,3,4,{dagger}, Aurélie Dipietromaria1,2,3,6,{dagger}, Marc Bailly-Bechet7, Frank Batista1,2,3, Marc Fellous1,2, Daniel Vaiman1,2,3 and Reiner A. Veitia1,2,3,4,*

1 INSERM U567, Team 21, Département de Génétique et Développement, Institut Cochin 75014, Paris, France 2 CNRS UMR8104, Institut Cochin, 75014 Paris, France 3 Université Paris Descartes, Faculté de Médecine Cochin-Port-Royal, Paris 75014, France 4 Université Denis Diderot, Paris VII, 75013 Paris, France 5 École Normale Supérieure, 75005 Paris, France 6 Université Paris-Sud, Paris XI, 91400 Orsay, France 7 TCI Microsoft Research, Dipartimento di Fisica, Politecnico de Torino, 10129 Torino, Italia

* To whom correspondence should be addressed at: INSERM E21-GDPM, Institut Cochin, 24, Rue du Faubourg Saint-Jacques, 75014 Paris, France. Tel: +33 144412301; Fax: +33 144412302. Email: veitia{at}cochin.inserm.fr

Received June 17, 2008; Accepted July 15, 2008

The Forkhead transcription factor FOXL2 plays a crucial role in ovarian development and maintenance. In humans, its mutations lead to craniofacial abnormalities, isolated or associated with ovarian dysfunction. Using a combinatorial approach, we identified and characterized a FoxL2 response element (FLRE) and showed that it is highly specific and that it diverges from that of other Forkhead transcription factors. This specificity should prevent aberrant regulation of FOXL2 targets by other members of the family and should prevent ectopic activation of the ovarian differentiation program in testes. We provide evidence that the FLRE is used in naturally occurring promoters. We show that polyAlanine expansions of FOXL2, which are the most frequent pathogenic mutations, induce a length-dependent loss of response on different artificial promoter reporters depending on the number and sequence of the FLREs that they contain. Thus, we provide clear mechanistic evidence explaining how the architecture of promoters influences their sensitivity to decreased transcription factor availability. Furthermore, we speculate that the generally absent ovarian phenotype of patients carrying the most frequent polyAlanine expansion should come from its ability to properly regulate high-affinity ovarian targets. The existence of critical high-affinity ovarian targets would be compatible with the role of FOXL2 in reproduction and ensure developmental and functional robustness. Taken together, our results give mechanistic insights on the molecular pathogenesis of FOXL2 polyAlanine expansions.


{dagger} The authors wish it to be known that, in their opinion, the first three authors should be regarded as joint First Authors.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Mol. Endocrinol.Home page
P. Lamba, J. Fortin, S. Tran, Y. Wang, and D. J. Bernard
A Novel Role for the Forkhead Transcription Factor FOXL2 in Activin A-Regulated Follicle-Stimulating Hormone {beta} Subunit Transcription
Mol. Endocrinol., July 1, 2009; 23(7): 1001 - 1013.
[Abstract] [Full Text] [PDF]


Home page
J. Med. Genet.Home page
P Laissue, B Lakhal, B A Benayoun, A Dipietromaria, R Braham, H Elghezal, P Philibert, A Saad, C Sultan, M Fellous, et al.
Functional evidence implicating FOXL2 in non-syndromic premature ovarian failure and in the regulation of the transcription factor OSR2
J. Med. Genet., July 1, 2009; 46(7): 455 - 457.
[Abstract] [Full Text] [PDF]


Home page
Hum Mol GenetHome page
B. A. Benayoun, F. Batista, J. Auer, A. Dipietromaria, D. L'Hote, E. De Baere, and R. A. Veitia
Positive and negative feedback regulates the transcription factor FOXL2 in response to cell stress: evidence for a regulatory imbalance induced by disease-causing mutations
Hum. Mol. Genet., February 15, 2009; 18(4): 632 - 644.
[Abstract] [Full Text] [PDF]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.